G

Gordian Biotechnology

Biotech firm developing aging-related therapies

Senior Scientist 1/2 - In Vivo Biology, Cardiometabolic and Renal

Translational Research & Bench BiologyUpdated on Nov 16
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • Have cardiometabolic or renal in vivo expertise, including personally running and interpreting rodent obesity and metabolic efficacy studies and/or heart failure, kidney, or atherosclerosis models where results drove a decision.
  • Have a PhD and 3–7 years of in vivo work in industry discovery programs, or equivalent depth from longer industry experience.
  • Have personally run mouse and rat studies for around ten years, including training, and be able to perform dosing by intraperitoneal, oral, subcutaneous, and intravenous routes, blood collection, takedowns, and tissue harvest.
  • Be able to recognize, teach, and diagnose good and poor study technique, and be willing to spend most of the week at the bench.
  • Have designed in vivo studies whose results determined whether a target advanced or stopped, including sizing groups from power calculations and selecting interpretable controls and timepoints.
  • Be able to assess which targets are most suitable for drug discovery, not merely execute studies.
  • Be able to explain results and limitations to biology, chemistry, and computational colleagues, challenge studies that cannot answer the question, and present data clearly to partners.

Responsibilities

  • Own one or two disease programs and target validation across screening, target validation, and drug discovery workstreams.
  • Plan and execute the in vivo portions of disease-area screens with screening and computational teams so generated hits are clean.
  • Set the validation strategy for programs, selecting targets, testing order, and the evidence required for drug discovery; recommend advancing, stopping, or further testing each target.
  • Design and run pharmacodynamic and efficacy studies for discovery targets, including small-molecule programs, and work with medicinal chemistry on the in vivo data needed for each molecule.
  • Design program experiments, including models, modalities, doses, routes, controls, timepoints, group sizes, and statistical power; use pilot studies and establish exposure and pharmacodynamics before efficacy when appropriate, and communicate the limits of each design.
  • Select oligonucleotides, AAV, or small molecules according to the experimental question, and establish new disease models, delivery routes, and readouts when existing approaches are insufficient.
  • Work with screening, computational, ex vivo and assay, and medicinal chemistry teams, presenting results and the decisions they support.
  • Lead a team of research associates and senior research associates, run the weekly in vivo meeting, and own vivarium operations and IACUC compliance through the Vivarium Manager.
  • Run studies personally, train team members on techniques until they can perform them reliably, hand over established techniques, and set up subsequent techniques, models, or readouts.
  • Perform dosing and takedowns during crunch periods and participate in weekend check rotations.
  • In the first month, learn the platform and in vivo obesity work, personally perform dosing and a takedown in the vivarium, start weekly one-to-ones with the team and Vivarium Manager, run the weekly in vivo meeting, and explain program status and upcoming decisions.
  • By two months, understand the heart failure and kidney work, join the weekend check rotation, and independently own day-to-day study design, protocols, and vivarium operations.
  • By three months, prepare a written target validation plan for each program covering targets, evidence thresholds, studies, timelines, and resources; document, teach, and hand over at least one core technique; and run in vivo work for the major pharma partnership to plan.
  • By six months, deliver decision-ready validation data and a recommendation for at least one target; keep screening and drug-discovery work on schedule without studies repeated due to design or execution errors; establish and validate one new technique, model, or readout; and have at least one team member own a study end to end.

Desired Qualifications

  • Experience managing research associates.
  • In vivo pharmacology experience with exposure and pharmacokinetic sampling, dose selection from pharmacokinetics, and target engagement versus phenotype.
  • Experience on small-molecule drug discovery programs.
  • In vivo experience with oligonucleotides such as antisense oligonucleotides or siRNA, or with AAV and gene therapy.
  • Direct experience with HFpEF, CKD, or atherosclerosis models.
  • Advanced phenotyping experience, including echocardiography, invasive hemodynamics, indirect calorimetry, EchoMRI or DEXA, glucose tolerance tests, or clamps.
  • Experience authoring IACUC protocols and running vivarium operations.
  • Experience with target discovery from genetic or screen-derived hits.
  • Experience managing CRO in vivo or pharmacokinetic studies.

About the Company

Gordian Biotechnology

Biotech firm developing aging-related therapies

Gordian Bio develops and licenses therapies aimed at age-related diseases by focusing on aging biology. It uses advanced laboratory models to study aging processes and test potential treatments in settings that resemble human conditions. The company emphasizes gene therapy and genome engineering to create therapies, and collaborates with pharmaceutical companies, research institutions, and healthcare providers through partnerships and licensing deals. Its approach centers on using animal models, such as fruit flies, to scale aging research and improve the relevance of findings for human health. This helps them move therapies toward clinical use by validating treatments in conditions closer to human biology. The company’s goal is to extend healthy human lifespan by addressing the root causes of aging-related diseases, ultimately improving healthspan for people.

Company size
11-50
Company stage
Early VC
Total funding
$61M
Headquarters
South San Francisco, CA
Founded
1990

Recently Posted Jobs

Explore more opportunities at Gordian Biotechnology

See more jobs